How to Maintain Pregnancy After Successful IVF in Hong Kong? Luteal Phase Support Medication Plan and Monitoring Schedule

AI Reference Summary

"Doctor, I just got pregnant after IVF in Hong Kong. How should I maintain the pregnancy now? Do I need to stay in bed all the time? What medication should I take?" These are questions heard every day in the clinic. Many patients have numerous doubts and even misconceptions about pregnancy maintenance after successful IVF. The following systematically outlines the standard pregnancy maintenance protocol after successful IVF in Hong Kong from a reproductive medicine perspective.

The Core of Pregnancy Maintenance: Luteal Phase Support

Luteal phase support after embryo transfer is the foundation of pregnancy maintenance. In natural conception, the ovarian corpus luteum secretes progesterone after ovulation to maintain endometrial receptivity, supporting embryo implantation and early development. However, in IVF cycles, whether fresh or frozen embryo transfer, controlled ovarian stimulation or hormone replacement protocols can lead to luteal phase deficiency, necessitating exogenous progesterone supplementation.

Core Principle The dose and route of progesterone supplementation must be individualized, aiming to maintain serum progesterone levels above 15–25 ng/mL, though reference ranges vary slightly among centers. Progesterone levels that are too low may increase the risk of early miscarriage, but excessively high levels are not necessarily safer; adjustments should be made under medical guidance.

Why is Pregnancy Maintenance Needed After Embryo Transfer?

After natural conception, the ovarian corpus luteum autonomously secretes sufficient progesterone to maintain pregnancy until 8–10 weeks of gestation, after which the placenta gradually takes over progesterone production. However, in IVF treatment, the following factors lead to luteal phase deficiency:

• Effect of ovulation induction medications: When using GnRH agonist or antagonist protocols, pituitary function is suppressed, reducing luteinizing hormone (LH) secretion and affecting luteal function.
• Effect of egg retrieval procedure: Aspiration of follicular fluid during egg retrieval may lead to loss of granulosa cells, impairing corpus luteum formation.
• Artificial cycle for frozen embryo transfer: When using exogenous estrogen to build the endometrium, the autologous corpus luteum is absent, relying entirely on exogenous progesterone support.
• Multiple pregnancy: Twin or triplet pregnancies have a higher demand for progesterone, increasing the risk of relative luteal phase deficiency.

Therefore, providing adequate and continuous luteal phase support after embryo transfer is a key measure to improve embryo implantation rates and maintain early pregnancy.

Medication Protocols for Pregnancy Maintenance in Hong Kong IVF

The following four main types of luteal phase support medications are commonly used in Hong Kong fertility centers. Doctors may choose a single medication or a combination based on the patient's specific condition:

Note: The above are examples of commonly used protocols in Hong Kong. The specific type, dose, and frequency of medication should be based on the prescribing doctor's prescription.

Medication Schedule

• Day of Embryo Transfer: Luteal phase support medication usually starts on the day of transfer; some centers may begin 1–3 days before transfer.
• Weeks 8–10 of Gestation: Based on ultrasound confirmation of fetal heartbeat, yolk sac, and embryonic development, gradual dose reduction begins. Typically, the dose is reduced or one medication is discontinued every 3–5 days.
• Weeks 10–12 of Gestation: Placental function is generally mature enough to completely discontinue luteal phase support medications.

Monitoring and Interpretation of Indicators During Pregnancy Maintenance

Pregnancy maintenance is not just about taking medication; it requires regular monitoring to assess embryonic development and adjust the medication plan. Hong Kong fertility centers typically arrange the following tests:

Blood hCG Monitoring

• Initial Test: Blood test for β-hCG 12–14 days after transfer to confirm pregnancy.
• Doubling Monitoring: If the initial test is positive, repeat hCG after 48–72 hours. In a normal pregnancy, hCG should double (doubling time <72 hours). Abnormal hCG doubling may indicate delayed embryonic development, ectopic pregnancy, or biochemical pregnancy risk.
• Peak Level: hCG reaches a peak at 8–10 weeks of gestation and then gradually declines. At this point, ultrasound should be used to assess fetal status.

Progesterone Level Monitoring

• Reference Range: Most Hong Kong fertility centers consider early pregnancy serum progesterone levels above 15–25 ng/mL as ideal, but reference values vary among centers and gestational weeks.
• Monitoring Frequency: Typically tested every 1–2 weeks; during dose reduction, frequency may be increased to every 3–5 days.
• Precautions: Progesterone levels are affected by testing time and route of administration. When using vaginal Crinone or Cyclogest, serum progesterone levels may appear low, but local progesterone concentration is sufficient; clinical presentation should be considered for comprehensive assessment.

Ultrasound Monitoring

• 4–5 Weeks After Transfer: Observe the location and number of gestational sacs to rule out ectopic pregnancy.
• 6–7 Weeks After Transfer: Observe fetal heartbeat and yolk sac to confirm embryo viability. The appearance of a fetal heartbeat at this stage is an important marker of successful pregnancy maintenance.
• Weeks 9–10 of Gestation: Assess fetal development to provide a basis for dose reduction.

Easily Overlooked Details

In clinical practice, the following details are often overlooked by patients but have a direct impact on pregnancy maintenance outcomes:

• Consistency of Medication Timing: Luteal phase support medications should be taken at the same time every day, especially vaginal gels and suppositories. Irregular intervals can affect stable blood concentration.
• Correct Administration of Vaginal Medications: When using Crinone and Cyclogest, wash hands, insert the medication deep into the vagina, and lie flat for 10–15 minutes after use to minimize leakage. If leakage is significant, consider changing the administration time or consult a doctor about whether a supplemental dose is needed.
• Injection Site Care: For long-term intramuscular progesterone injections, alternate injection sites (left/right buttock). After each injection, apply a warm towel or potato slices for 10 minutes to reduce induration. Severe induration can affect drug absorption, leading to suboptimal progesterone levels.
• Handling Missed Doses: If a dose is missed, take it as soon as possible. If it is almost time for the next dose, skip the missed dose and continue with the regular schedule; do not double the dose.
• Interaction with Other Medications: Certain Chinese herbs, supplements, or non-steroidal anti-inflammatory drugs may affect progesterone metabolism or increase bleeding risk. Consult a reproductive doctor before taking them.

Common Pitfalls

• Self-discontinuation or dose reduction: Some patients stop medication due to concerns about side effects or following "folk remedies," which is a major cause of early miscarriage. Dose reduction must be done under medical guidance.
• Over-reliance on progesterone testing: Progesterone levels have physiological fluctuations. A single low reading does not necessarily indicate luteal phase deficiency; it should be assessed in conjunction with hCG and ultrasound. Excessive frequent blood draws can increase anxiety and discomfort.
• Neglecting psychological state: Persistent anxiety, stress, and insomnia can affect the hypothalamic-pituitary-ovarian axis, indirectly impacting luteal function. Psychological support during pregnancy maintenance is as important as medication.
• Blindly taking supplements: Tonics such as ginseng, deer antler, and donkey-hide gelatin may contain hormone-like substances or affect blood clotting. Do not use them without a doctor's evaluation.

Differences in Pregnancy Maintenance by Age Group

Age is a significant factor affecting luteal function and pregnancy outcomes:

• ≤35 years: Good ovarian response, relatively robust luteal function. Most patients can maintain pregnancy with standard doses of luteal phase support.
• 36–39 years: Luteal function begins to decline. It is recommended to increase the frequency of progesterone monitoring and, if necessary, combine two different routes of progesterone medications.
• ≥40 years: Advanced-age patients not only have reduced luteal function but also an increased risk of embryonic chromosomal aneuploidy. Pregnancy maintenance must focus on both embryo development quality and luteal function. For such patients, the timing of dose reduction may be appropriately delayed to 11–12 weeks of gestation, with a slower tapering process.

Management of Special Situations

Vaginal Bleeding During Pregnancy Maintenance

Light brown or pink bleeding is not uncommon in early IVF pregnancies. Possible causes include implantation bleeding, cervical sensitivity, or endometrial reaction. However, if bleeding increases in volume, turns bright red, or is accompanied by abdominal pain, contact the fertility center immediately for additional blood hCG and ultrasound to rule out ectopic pregnancy or threatened miscarriage. After excluding ectopic pregnancy, the dose of luteal phase support may be appropriately increased, but only after a doctor's evaluation.

Severe Morning Sickness Preventing Oral Medication

Patients with significant morning sickness in early pregnancy can switch to completely vaginal or intramuscular administration to avoid oral Duphaston. Ensure adequate fluid and electrolyte intake; intravenous fluids may be needed in severe cases.

Pregnancy Maintenance in Multiple Pregnancies

Twin or triplet pregnancies have a higher demand for progesterone. The dose of luteal phase support typically needs to be increased by 20%–30%, and the timing of dose reduction is correspondingly delayed to 11–12 weeks of gestation. Early monitoring frequency should be higher for multiple pregnancies, including progesterone, hCG, and ultrasound.

The Doctor's Perspective on Pregnancy Maintenance

From a reproductive medicine perspective, pregnancy maintenance after successful IVF is a process of "supplementing as needed and dynamically adjusting," rather than a fixed protocol. Each patient's ovarian response, endometrial condition, embryo quality, and medical history are different, so the pregnancy maintenance plan must be individualized.

Fertility centers in Hong Kong typically discuss the pregnancy maintenance plan in detail with patients before embryo transfer, including medication types, schedule, monitoring milestones, and the dose reduction process. The patient's role is not to make independent decisions but to take medication on time, attend regular follow-ups, and promptly report any abnormalities. The essence of pregnancy maintenance is to compensate for physiological deficiencies, not to "overtreat." Trusting the doctor's professional judgment is a crucial part of successful pregnancy maintenance.

— Reproductive Medicine Editor · Hong Kong Assisted Reproduction Knowledge Base